Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomater Appl ; 33(10): 1407-1414, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30885033

RESUMO

Anterior cruciate ligament reconstruction using polyethylene terephthalate artificial ligaments is one of the research hotspots in sports medicine but it is still challenging to achieve biological healing. The purpose of this study was to modify polyethylene terephthalate ligament with silk fibroin through ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/N-hydroxysuccinimide (NHS) crosslink and to investigate the performance of graft remodeling in vitro and in vivo. After silk fibroin coating, changes in the surface properties of ligament were characterized by scanning electron microscopy, attenuated total reflectance-Fourier transform infrared spectroscopy and water contact angle measurements. The compatibility of polyethylene terephthalate ligament with silk fibroin coating was investigated in vitro. The results showed the silk fibroin coating significantly improved adhesion, proliferation and extracellular matrix secretion of fibroblast cells. Moreover, a rabbit anterior cruciate ligament reconstruction model was established to evaluate the effect of ligament with silk fibroin coating in vivo. The gross observation and histological results showed that the silk fibroin coating significantly inhibited inflammation response and promoted new tissue regeneration with fusiform cells infiltration in and around the graft. Furthermore, the expressions of collagen I protein and mRNA in the silk fibroin-coated polyethylene terephthalate group were much higher than those in the control group according to the immunohistochemical and real-time polymerase chain reaction results. Therefore, silk fibroin coating through EDC/NHS crosslink promotes the biocompatibility and remodeling process of polyethylene terephthalate artificial ligament in vitro and in vivo. It can be considered as a potential solution to the problem of poor remodeling of artificial ligaments after anterior cruciate ligament reconstruction in the clinical applications.


Assuntos
Lesões do Ligamento Cruzado Anterior/terapia , Ligamento Cruzado Anterior/cirurgia , Materiais Revestidos Biocompatíveis/uso terapêutico , Fibroínas/uso terapêutico , Polietilenotereftalatos/uso terapêutico , Animais , Linhagem Celular , Materiais Revestidos Biocompatíveis/química , Reagentes de Ligações Cruzadas/química , Reagentes de Ligações Cruzadas/uso terapêutico , Etildimetilaminopropil Carbodi-Imida/química , Etildimetilaminopropil Carbodi-Imida/uso terapêutico , Fibroblastos/citologia , Fibroínas/química , Masculino , Camundongos , Polietilenotereftalatos/química , Coelhos , Succinimidas/química , Succinimidas/uso terapêutico , Propriedades de Superfície
2.
Ann Thorac Surg ; 79(3): 905-10, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15734403

RESUMO

BACKGROUND: Bifunctional amines were previously found to act as bridging molecules between the terminal ends of incomplete glutaraldehyde (GA) cross-links. The additional cross-links thus formed between -NH2 groups of tissue were seen to significantly inhibit bioprosthetic calcification. In the current study, the potential ability of alpha-amino oleic acid (AOA) to act as a bridging molecule between -NH2- and COOH-dependent cross-links was hypothesized to similarly augment the anticalcification effect of the AOA molecule. METHODS: Porcine aortic wall tissue from Medtronic Freestyle valve bioprostheses incorporating the AOA anticalcification process additionally underwent carboxyl-group cross-linking with Jeffamine (poly[propylene glyco]-bis-[aminopropyl ether]) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). Tissue was subdermally implanted into 5-week-old Long-Evans rats for 60 days. Standard 0.2% GA-fixed tissue served as a control. To further assess the impact of storage solution on AOA tissue, samples were either stored in GA (0.2%GA) or EDC (25 mmol/L carbodiimide) before implantation. Tissue calcification was assessed by atomic absorption spectroscopy and histochemical staining. RESULTS: Aldehyde end-capping with AOA achieved only a modest reduction of calcification in GA-treated aortic wall tissue (-20.0%; p < 0.05). Replacing GA with EDC as a storage solution led to a further 32.4% (p < 0.01) mitigation of calcification in Freestyle tissue. Incorporating an intermediate EDC/Jeffamine cross-linking step achieved a distinct additional reduction of calcification by 40.4% (p < 0.05). Overall, aortic wall calcification was 59.7% (p < 0.0001) lower if commercial Freestyle tissue underwent an additional EDC/Jeffamine cross-linking step and subsequent storage in EDC. Relative to control GA-fixed tissue, this represented a 67.8% (p < 0.0001) reduction. Incorporation of AOA was essential for the beneficial effect of the additional EDC/Jeffamine cross-linking step. CONCLUSIONS: Potentially utilizing both the amino- and the carboxyl moieties of AOA for tissue binding dramatically reduces aortic wall calcification of GA-fixed tissue.


Assuntos
Doenças da Aorta/prevenção & controle , Bioprótese , Calcinose/prevenção & controle , Etildimetilaminopropil Carbodi-Imida/uso terapêutico , Ácidos Oleicos/uso terapêutico , Animais , Aorta Torácica , Doenças da Aorta/etiologia , Bioprótese/efeitos adversos , Calcinose/etiologia , Sinergismo Farmacológico , Etildimetilaminopropil Carbodi-Imida/farmacologia , Fixadores , Glutaral , Masculino , Ácidos Oleicos/farmacologia , Ratos , Ratos Long-Evans
4.
Experientia ; 32(2): 231-2, 1976 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-1269623

RESUMO

Regression of TA3 ascites carcinoma tumors occurred following i.p. injection of 1-ethyl-3-(3'-dimethylaminopropyl)carbodiimide-HC1. An immunological mechanism of drug action was indicated by the fact that no significant antitumor activity was demonstrable in mice that had previously received an immunosuppressive 700 rad dose of 60Co radiation.


Assuntos
Carbodi-Imidas/uso terapêutico , Carcinoma/tratamento farmacológico , Etildimetilaminopropil Carbodi-Imida/uso terapêutico , Animais , Ascite , Carcinoma/imunologia , Linhagem Celular , Radioisótopos de Cobalto , Rejeição de Enxerto , Terapia de Imunossupressão , Camundongos , Transplante de Neoplasias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...